Archives

by in
Entry Author Date Location
An OVP IPO is Brewing, Allozyne Doing Fine, VLST Finds Second Partner, & More Tidbits from the OVP Tech Summit 05/04/10 Seattle
Bruce Montgomery Joins Zymo Board 03/11/10 Seattle
Amylin, Alkermes Sit in Suspense For FDA Verdict on Once-Weekly Diabetes Drug 03/10/10 National
A Brief Year-End Review of Seattle Biotech 12/31/09 Seattle
Cell Therapeutics Dangles Exec Bonuses, Oncothyreon’s Turnaround Year, VLST Layoffs, & More Seattle-Area Life Sciences News 12/24/09 Seattle
VLST Cuts Jobs To Preserve Cash, Still Feeding Novo Nordisk Pipeline 12/22/09 Seattle
Dendreon Grasps for $400M, ZymoGenetics Cuts 52 Jobs, Calistoga Advances at ASH, & More Seattle-Area Life Sciences News 12/10/09 Seattle
ZymoGenetics Sells Inflammatory Drug to Old Parent, Novo Nordisk, for $24M Upfront 12/08/09 Seattle
So Much For Gardening: Bruce Carter Joins Vaccine Startup Immune Design To Raise Cash 11/23/09 Seattle
Lee Hood’s New Idea, Calypso Scores $50M, Novo’s Historic Mistake Pays Off for Seattle, & More Seattle-Area Life Sciences News 09/25/09 Seattle
Novo Nordisk’s Historic Mistake is Seattle’s Future Gain, Says Novo CEO 09/18/09 Seattle
CombiMatrix Reinvents Itself From Lab Toolmaker to Cancer Diagnostics Player 06/17/09 Seattle
Anadys Cuts Jobs, Obesity Drug Developers Show Intriguing Results, Trius Antibiotic Passes Key Test, & More San Diego Life Sciences News 06/11/09 San Diego
Departed Amylin Co-Founder Greene Says Company in ‘Perfect Storm,’ But Confident in Management 04/13/09 San Diego
Dendreon Saga Nears Climax, Gregoire Biotech Fund in Jeopardy, UW’s Biofuel Futurist, & More Seattle-Area Life Sciences News 04/09/09 Seattle
Swype Scores $1.3M, Onehub Raises $600K, Genzyme Comes to Town, & More Seattle-Area Deals News 04/07/09 Seattle
Biotech Neighbors, VLST and Novo Nordisk, Forge Alliance in Seattle’s South Lake Union 04/06/09 Seattle
UW’s Gardasil Connection Generates Windfall for Research, Tech Transfer 02/23/09 Seattle
The Show Must Go On: Invest Northwest Forges Ahead Despite Grim Biotech Climate 02/17/09 Seattle
Lenovo Buys Switchbox, Ekos Raises $12.5M, nLight Lands $10.7M, & More Seattle-Area Deals News 02/03/09 Seattle
Seattle Genetics Raises Dough, Trubion Feels Fallout of Pfizer Deal, Novo Sets Up Shop, & More Seattle-Area Life Sciences News 01/29/09 Seattle
ZymoGenetics Takes Back Full Rights to Cancer Drug Candidate 01/28/09 Seattle
Riding the Diabetes Wave, Novo Nordisk Sees Chance to Scoop Up Biotech Talent in Seattle 01/28/09 Seattle
3Tier Group Gets $10M, Socialmedian Sold for $7.5M, Gates Gives $7M to IDRI, & More Seattle-Area Deals News 12/23/08 Seattle
Amgen Tries to “Personalize” Drug, VLST Snags Deal, Tobacco Money Backs Research, & More Seattle-Area Life Sciences News 12/18/08 Seattle
VLST Snags Partnership with Novo Nordisk to Develop New Drugs for Autoimmunity 12/17/08 Seattle
Who’s Hiring in Seattle Biotech? It’s Not All Layoffs, All the Time 12/10/08 Seattle
ZymoGenetics CEO Bruce Carter Retires, Promotes Doug Williams, Says Sad Goodbyes to Biotech “Family” 11/21/08 Seattle
Merck Bails on Seattle, Gates Foundation Backs Far-Out Ideas, Zymo Drug Shows Promise & More Seattle-Area Life Sciences News 10/23/08 Seattle
Vulcan’s Healey “Disappointed” in Merck Shutdown, But Says Other Tenants May Fill Void 10/22/08 Seattle
Page 2 of 3 « previous page · next page »